June 19-25, 2023 - Colorado Convention Center, Denver, CO

Media

To request a media pass or interview or appearance, please complete the media request form and a member of our communications team will be in touch if we are able to grant an interview.

Psychedelic Science Conference Media Coverage

The New York Times (2017)

Molly at the Marriott: Inside America’s Premier Psychedelics Conference
“Rather than rock stars, scientists from schools like Johns Hopkins and N.Y.U. were the main attraction, bringing evidence to the medical case for psychedelics like psilocybin (the active ingredient in magic mushrooms) to assuage end-of-life anxiety, to help deepen meditation practices, to search for the shared underpinnings of spiritual life, and — in a new study — to explore a possible treatment for severe depression.”

Scientific American (2017)

Psychedelic Compound in Ecstasy Moves Closer to Approval to Treat PTSD
“Last week, at the Psychedelic Science 2017 conference in Oakland, California, researchers presented unpublished results from phase II trials involving a total of 107 people diagnosed with PTSD. The trial treatment involved a combination of psychotherapy and MDMA (3,4-methylenedioxymethamphetamine).”

WIRED (2013)

Open Your Mind to the New Psychedelic Science
“Several scientists at the conference pointed to findings that activity in the brain’s default mode network is elevated in people with depression. Because psilocybin and ayahuasca seem to dampen activity in this network, perhaps they could help.”

New Scientist (2018)

Mind Menders: How Psychedelic Drugs Rebuild Broken Brains
“Last year, at the Psychedelic Science 2017 conference in Oakland, California, a group led by Michael Mithoefer at the Medical University of South Carolina presented results from trials in which 107 people with PTSD underwent a psychotherapy while under the influence of MDMA.”

The Verge (2017)

LSD Microdoses Make People Feel Sharper, and Scientists Want to Know How
“The machinery of science moves much more slowly than hype. But the science is starting to catch up. The first glimpses of data on microdosing were presented on April 21, at Psychedelic Science 2017, a six-day summit in Oakland of more than 100 clinical researchers and physicians and 2,500 psychedelic enthusiasts.”

Fox News (2013)

Psychedelic Science Conference Highlights Therapeutic Benefits of Mind-Altering Drugs
“The psychedelic movement of the 1960s and 70s ended with the enactment of federal laws making most of these drugs illegal. But psychedelics have moved on, into laboratories, hospitals and clinical settings where the use of mind-altering drugs has been intensively studied for their unique benefits to health – especially mental health.”

Reason (2017)

Medical Researchers Are Steps From Legalizing Ecstasy. Here’s How They Did It.
“The Multidisciplinary Association for Psychedelic Studies (MAPS) hosted nearly 3,000 researchers, students, and enthusiasts for Psychedelic Science 2017, a six-day conference on what’s being done to turn illegal psychedelic drugs into legal pharmaceutical products.”

The Conversation (2018)

The Real Promise of LSD, MDMA and Mushrooms for Medical Science
“Boasting attendance of more than 3,000 participants, Psychedelic Science 2017 brought together researchers and practitioners with a diverse set of interests in reviving psychedelics — from filmmakers to neuroscientists, journalists, psychiatrists, artists, policy advisers, comedians, historians, anthropologists, Indigenous healers and patients.”

SF Weekly (2017)

The Biggest Psychedelics Conference Ever Starts Today in Oakland
“Psychedelic Science 2017 features more than 100 presentations regarding the therapeutic uses of psychedelics, the neuroscience behind this research, the spread of psychedelic culture into the mainstream, and more.”

Medical Express (2017)

Psychedelics in the Lab and Clinic—Making Up for Lost Time
“Scientists and clinicians presented evidence from ongoing research suggesting that psychedelics, used in a controlled psychotherapy setting, have the potential to alleviate conditions that don’t respond to conventional drugs and therapy, including depression, social anxiety, post-traumatic stress disorder and addiction.”

Leafly (2017)

Psychedelic Science 2017 Conference: Leafly Reports From the Front Lines
“Researchers from all over the globe will come together to deliver a wide range of topics, from psychiatric breakthroughs to exploring the boundaries of human consciousness.”

SF Station (2017)

10 Mind-Altering Sessions at Oakland’s Psychedelic Science Conference
“[Psychedelic Science 2017] will bring together international leaders in the sciences, medicine, education, public policy and arts who are studying the practical application of psychedelics for treating physical and mental disorders.”

East Bay Express (2017)

World’s Largest Psychedelic Drug Conference ‘Psychedelic Science 2017’ In Oakland This Week
“One only has to look at the potpourri of workshops by researchers and specialists worldwide that will descend on the conference: MDMA-assisted psychotherapy is the front-runner in medicalization, the family tree includes issues such as ayahuasca retreats, ketamine-assisted psychotherapy, psychedelic harm reduction at festivals, holotropic breathing, and LSD microdosing.”

Stop the Drug War (2013)

Psychedelic Science Conference Examines MDMA Treatment for PTSD
“Stretching over five days of workshops and conference presentations, the MAPS conference is perhaps the premier confab of psychedelic researchers worldwide. A look at just some of the topics covered in the remarkably broad-ranging affair makes that case.”